BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Clinical trial NCT01870505 · COMPLETED
Trial details
- NCT number
- NCT01870505
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2022-02-28
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.